Cytosorbents Corporation
CTSO
$0.93
$0.02372.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.75M | -15.99M | -20.60M | -19.29M | -26.15M |
| Total Depreciation and Amortization | 1.70M | 1.71M | 1.74M | 2.11M | 2.14M |
| Total Amortization of Deferred Charges | 761.80K | 560.50K | 380.80K | 190.40K | 0.00 |
| Total Other Non-Cash Items | -3.12M | 4.06M | 8.73M | 1.30M | 6.68M |
| Change in Net Operating Assets | 625.80K | -3.40M | -4.68M | -2.80M | -3.91M |
| Cash from Operations | -9.78M | -13.06M | -14.43M | -18.49M | -21.24M |
| Capital Expenditure | -259.90K | -240.80K | -283.90K | -310.20K | -300.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -341.60K | -347.90K | -384.60K | -370.00K | -338.70K |
| Cash from Investing | -601.60K | -588.80K | -668.60K | -680.30K | -639.60K |
| Total Debt Issued | 0.00 | 15.00M | 15.00M | 15.00M | 15.00M |
| Total Debt Repaid | 0.00 | -4.38M | -5.00M | -5.00M | -5.00M |
| Issuance of Common Stock | 7.00M | 7.00M | 220.10K | 12.26M | 12.91M |
| Repurchase of Common Stock | -42.60K | -41.70K | -41.70K | -41.70K | -200.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -57.60K | -847.60K | -847.60K | -847.60K | -790.00K |
| Cash from Financing | 6.90M | 16.73M | 9.33M | 21.37M | 22.12M |
| Foreign Exchange rate Adjustments | 264.30K | -64.60K | -84.70K | -77.40K | -139.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.22M | 3.02M | -5.85M | 2.12M | 105.10K |